Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020
Open Access
- 14 March 2023
- journal article
- research article
- Published by Wiley in Thoracic Cancer
- Vol. 14 (11), 992-1003
- https://doi.org/10.1111/1759-7714.14835
Abstract
Background: Esophageal cancer (EC) is a global health problem. Asia represents a huge burden of EC globally, and incidence and mortality vary considerably across different Asian regions.Methods: Data on incidence, mortality, and preference were extracted from GLOBOCAN 2020. Age-standardized incidence and mortality rates were calculated overall by sex, age, country, region, and continent. The predicted burden of incidence and mortality in 2040 was calculated based on global demographic projections.Results: It was estimated there were 481 552 new cases of and 434 363 deaths from EC in Asia in 2020, accounting for 79.7% and 79.8% of world EC cases and deaths, respectively. EC incidence and mortality in Asia ranked the highest among all continents. Eastern Asia represents the highest age-standardized world incidence rate (ASWIR) of 12.3 per 100 000 for all Asian regions. Western Asia represents the lowest ASWIR of 1.7 per 100 000, accounting for 0.7% of the globe. There exist obvious differences in epidemiological features in Asian countries, including incidence, mortality, prevalence, and mortality incidence ratio. There is forecast to be up to 781 000 new cases of EC in Asia by 2040, with increasing rates of 63% for incidence and 72% for mortality from 2020.Conclusions: Asia has an increasing number of EC cases and deaths. Strategies for targeting in high-incidence areas, the elderly, and survival should be prioritized to reduce the global EC burden, especially in low-and middle-income countries in Asia.Keywords
Funding Information
- Chinese Society of Clinical Oncology (Y‐Young2020‐0003)
- National Natural Science Foundation of China (82102827)
This publication has 48 references indexed in Scilit:
- Expanding global access to radiotherapyThe Lancet Oncology, 2015
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialThe Lancet Oncology, 2015
- Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in ChinaJournal of Clinical Oncology, 2015
- Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populationsNature Genetics, 2014
- Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactionsNature Genetics, 2012
- The Anyang Esophageal Cancer Cohort Study: Study Design, Implementation of Fieldwork, and Use of Computer-Aided Survey SystemPLOS ONE, 2012
- Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populationsNature Genetics, 2011
- Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1Nature Genetics, 2010
- A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinomaNature Genetics, 2010
- Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: A population-based cohort study (JPHC study)Cancer Letters, 2009